Moras M, Lefevre SD, Ostuni MA
Medications make more sense for people with significant weight to lose for health reasons, those with type 2 diabetes or prediabetes where GLP-1 receptor agonists address both conditions simultaneously, individuals who have tried lifestyle changes and supplements without adequate results, and anyone whose healthcare provider recommends pharmaceutical intervention based on risk assessment
Intramuscular injections (IM): Faster absorption, slightly harder to self-administer
Mongongu C, Coudore F, Domergue V, et al
[12] Retatrutide's development trajectory suggests it may eventually progress through the regulatory approval process, but no confirmed timeline for a UK licence application has been publicly announced